Investing in crypto-assets carries risks of liquidity, volatility, and partial or total capital loss. Crypto-assets held are not covered by deposit and securities guarantee mechanisms.
Sign up for our newsletter
Partners
Coinhouse
Our accounts
2025 - all right reserved - coinhouse
Coinhouse
Coinhouse SAS with a capital of €210,000, RCS Paris 815 254 545, headquarters: 14 Avenue de l'Opéra 75001 Paris – support@coinhouse.com. Registered with the AMF for activities related to the purchase/sale of digital assets against legal tender, the exchange of digital assets for other digital assets, and the custody of digital assets for third parties under the registration number: E2020-001.
Coinhouse payment solutions
Company registered with the Paris RCS under the number 914 384 557, registered with the Prudential Control and Resolution Authority as a payment service agent under the number 727503 of the electronic money institution Treezor, headquartered at 33 Avenue de Wagram, 75017 Paris.
General conditions, disclaimers and legal documents.
Injective Protocol (INJ), is an ultra-fast blockchain that provides the resources needed to create decentralized trading applications (DeFi).
Together with helix, Injective offers the ability to trade various financial instruments such as futures, perpetual swaps, CFDs, indices and equity derivatives, all in a completely decentralized environment.
Injective is based on Cosmos blockchain technology.
Injective Protocol was founded in 2018.
In 2020, Injective Protocol raised significant funds in its Initial Coin Offering (ICO).
The platform rapidly evolved, adding features such as spot and derivatives trading and developer tools.
In 2021 and 2022, Injective Protocol expanded its ecosystem, focusing on interoperability between different blockchains, notably Ethereum.
In 2023, Injective Protocol’s share price rose sharply (over 870%).
Injective Protocol (INJ) was created by Eric Chen and Albert Chon.
Injective Protocol’s investors include Pantera Capital, Binance, Hashed, Mark Cuban and other notable blockchain investors.
Injective Protocol offers all the tools needed to create first-class decentralized applications.
Its construction on the Cosmos blockchain ensures high interoperability and transaction speed, reinforcing its growth potential in the crypto-currency ecosystem.
The support of major investors and its innovative approach to decentralized finance position Injective Protocol as a promising investment in the DeFi field.
The token’s performance in 2023 indicates growing interest in the project from the web3 community and investors.
€ 9.27
INJ
Your questions Injective Protocol
Can't find your selection? Visit our help center.
Injective Protocol is a blockchain that enables the creation of decentralized applications in the field of DeFi (decentralized finance).
Injective Protocol stands out for its innovative DeFi decentralized applications, notably Helix, a decentralized derivatives exchange.
The aim of Injective Protocol is to provide a first-class platform for building high-performance decentralized applications in the DeFi domain.
BTC
Bitcoin
Est. 2009
€ 91 368
-0.6%
ETH
Ethereum
Est. 2014
€ 2 092.18
-1.4%
USDT
USDT
Est. 2014
€ 0.85
+0.1%
XRP
Ripple
Est. 2004
€ 1.79
-4%
SOL
Solana
Est. 2017
€ 121.50
-1.7%
USDC
USDC
Est. 2018
€ 0.85
+0.1%
DOGE
Dogecoin
Est. 2013
€ 0.14
-1.5%
ADA
Cardano
Est. 2015
€ 0.48
-2.1%
BCH
Bitcoin Cash
Est. 2017
€ 425.16
-0.8%
€ 9.27
-2.9 %
Information on the price
Price variation (24h)
-2.9 %All-time high
€ 48.29
Trading volume (24h)
€ 27 348 586.12
Price variation (7d)
-7.6 %All-time low
€ 0.56
Diluted valuation
€ 926 647 763
Price variation (30d)
-30 %Circulating supply
97 727 220,33 INJ
Total supply
100 000 000 INJ
Price variation (200d)
-68.9 %Market capitalization
€ 905 587 101
Max supply
-
Trading opportunity
Suggested entry price
Suggested entry price INJ
Recommendation
Recommendation INJ
Information reserved for premium offers subscribers.
Premium
Information reserved for premium offers subscribers.
Premium
